U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H28F7N5O2
Molecular Weight 575.5216
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of L-760735F

SMILES

C[C@@H](O[C@H]1OCCN(CC2=C(CN(C)C)N=NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F

InChI

InChIKey=USRYEHHMJIRICK-ZNZBMKLDSA-N
InChI=1S/C26H28F7N5O2/c1-15(17-10-18(25(28,29)30)12-19(11-17)26(31,32)33)40-24-23(16-4-6-20(27)7-5-16)38(8-9-39-24)14-22-21(13-37(2)3)34-36-35-22/h4-7,10-12,15,23-24H,8-9,13-14H2,1-3H3,(H,34,35,36)/t15-,23+,24-/m1/s1

HIDE SMILES / InChI

Molecular Formula C26H28F7N5O2
Molecular Weight 575.5216
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9733503 | https://www.ncbi.nlm.nih.gov/pubmed/11595206 | https://www.ncbi.nlm.nih.gov/pubmed/15875166 | https://www.ncbi.nlm.nih.gov/pubmed/26690860

L-760735 is a non-peptide substance P receptor (Neurokinin 1 (NK1) receptor) antagonist. It exerts anxiolytic, antidepressant and antinociceptive actions in animals. Merck was developing an L- 760735 as a potential antidepressant.

Originator

Curator's Comment: # Merck & Co

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.3 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat.
2016-03
Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
2015-08-15
Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters.
2005-09
The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.
2003-03
Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity.
2002-09-01
Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus.
2002
Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
2001-11
Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.
2001-10-12
Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs.
2001-07
The selective neurokinin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system.
2001-03
The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala.
1999-11-27
Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation.
1999
Distinct mechanism for antidepressant activity by blockade of central substance P receptors.
1998-09-11
An NK1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters.
1998-07-27
Patents

Patents

Sample Use Guides

Tree shrews were subjected to a 7-day period of psychosocial stress before receiving daily oral administration of L-760735 (10 mg/kg/day)
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Treatment of human intervertebral disc cells with L-760735 was able to suppress expression of IL-1β, IL-6, and IL-8 in a dose-dependent manner.
Unknown
Substance Class Chemical
Created
by admin
on Tue Apr 01 21:15:17 GMT 2025
Edited
by admin
on Tue Apr 01 21:15:17 GMT 2025
Record UNII
4I4P4I2E8P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1H-1,2,3-TRIAZOLE-4-METHANAMINE, 5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-N,N-DIMETHYL-
Preferred Name English
L-760735F
Code English
5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-N,N-DIMETHYL-1H-1,2,3-TRIAZOLE-4-METHANAMINE
Systematic Name English
Code System Code Type Description
CAS
171242-11-8
Created by admin on Tue Apr 01 21:15:17 GMT 2025 , Edited by admin on Tue Apr 01 21:15:17 GMT 2025
PRIMARY
PUBCHEM
9809077
Created by admin on Tue Apr 01 21:15:17 GMT 2025 , Edited by admin on Tue Apr 01 21:15:17 GMT 2025
PRIMARY
FDA UNII
4I4P4I2E8P
Created by admin on Tue Apr 01 21:15:17 GMT 2025 , Edited by admin on Tue Apr 01 21:15:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID90430978
Created by admin on Tue Apr 01 21:15:17 GMT 2025 , Edited by admin on Tue Apr 01 21:15:17 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY